These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 24440307)
1. Promising roles of mammalian E2Fs in hepatocellular carcinoma. Zhan L; Huang C; Meng XM; Song Y; Wu XQ; Miu CG; Zhan XS; Li J Cell Signal; 2014 May; 26(5):1075-81. PubMed ID: 24440307 [TBL] [Abstract][Full Text] [Related]
2. Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines. Baiz D; Dapas B; Farra R; Scaggiante B; Pozzato G; Zanconati F; Fiotti N; Consoloni L; Chiaretti S; Grassi G World J Gastroenterol; 2014 Jan; 20(3):795-803. PubMed ID: 24574752 [TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. Maiti B; Li J; de Bruin A; Gordon F; Timmers C; Opavsky R; Patil K; Tuttle J; Cleghorn W; Leone G J Biol Chem; 2005 May; 280(18):18211-20. PubMed ID: 15722552 [TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic role of E2F transcription factors in high-grade glioma. Yu H; Li Z; Wang M CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771 [TBL] [Abstract][Full Text] [Related]
5. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation. Deng Q; Wang Q; Zong WY; Zheng DL; Wen YX; Wang KS; Teng XM; Zhang X; Huang J; Han ZG Cancer Res; 2010 Jan; 70(2):782-91. PubMed ID: 20068156 [TBL] [Abstract][Full Text] [Related]
6. Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells. Farra R; Dapas B; Baiz D; Tonon F; Chiaretti S; Del Sal G; Rustighi A; Elvassore N; Pozzato G; Grassi M; Grassi G Biochimie; 2015 May; 112():85-95. PubMed ID: 25742740 [TBL] [Abstract][Full Text] [Related]
7. Prognostic values of Manicum T; Ni F; Ye Y; Fan X; Chen BC Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30487158 [TBL] [Abstract][Full Text] [Related]
8. PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma. Wang C; Xiao Y; Hu Z; Chen Y; Liu N; Hu G FEBS Lett; 2008 Aug; 582(18):2793-8. PubMed ID: 18625225 [TBL] [Abstract][Full Text] [Related]
9. E2F transcription factors and digestive system malignancies: how much do we know? Xanthoulis A; Tiniakos DG World J Gastroenterol; 2013 Jun; 19(21):3189-98. PubMed ID: 23745020 [TBL] [Abstract][Full Text] [Related]
11. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649 [TBL] [Abstract][Full Text] [Related]
12. The ancient function of RB-E2F pathway: insights from its evolutionary history. Cao L; Peng B; Yao L; Zhang X; Sun K; Yang X; Yu L Biol Direct; 2010 Sep; 5():55. PubMed ID: 20849664 [TBL] [Abstract][Full Text] [Related]
13. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma. Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181 [TBL] [Abstract][Full Text] [Related]
14. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Cartwright P; Müller H; Wagener C; Holm K; Helin K Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927 [TBL] [Abstract][Full Text] [Related]
15. Role of E2F transcription factor in oral cancer: Recent insight and advancements. Kassab A; Gupta I; Moustafa AA Semin Cancer Biol; 2023 Jul; 92():28-41. PubMed ID: 36924812 [TBL] [Abstract][Full Text] [Related]
17. Structural insights into the DNA-binding specificity of E2F family transcription factors. Morgunova E; Yin Y; Jolma A; Dave K; Schmierer B; Popov A; Eremina N; Nilsson L; Taipale J Nat Commun; 2015 Dec; 6():10050. PubMed ID: 26632596 [TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of E2F5/p130, but not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice. Chen Q; Liang D; Overbeek PA Mol Vis; 2008 Mar; 14():602-14. PubMed ID: 18385796 [TBL] [Abstract][Full Text] [Related]
20. Cellular transformation of mouse embryo fibroblasts in the absence of activator E2Fs. Gupta T; Sáenz Robles MT; Pipas JM J Virol; 2015 May; 89(9):5124-33. PubMed ID: 25717106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]